# Nektar Therapeutics: Form 8-K, filed Jun 5, 2026

- Company: [Nektar Therapeutics](/companies/nktr.md) (CIK 906709)
- Form: 8-K
- Filed: 2026-06-05
- Accepted by EDGAR: Jun 5, 2026, 20:30 ET
- Period: 2026-06-05
- Accession: 0001213900-26-065845
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/906709/000121390026065845/ea0293744-8k_nektar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/906709/000121390026065845/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/906709/000121390026065845/ea0293744-8k_nektar.htm

Filed Jun 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-065845. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.